Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia

Jose M. Mostaza, Isio Schulz, Gloria L Vega, Scott M Grundy

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Pravastatin treatment of combined hyperlipidemia lowers low-density lipoprotein effectively; nicotinic acid lowers remnant cholesterol and raises high-density lipoprotein. A combination of these 2 drugs may be indicated for optimal treatment of lipoprotein abnormalities in combined hyperlipidemia.

Original languageEnglish (US)
Pages (from-to)1298-1301
Number of pages4
JournalAmerican Journal of Cardiology
Volume79
Issue number9
DOIs
StatePublished - May 1 1997

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia'. Together they form a unique fingerprint.

Cite this